Singapore's Attogenix on course for late 2005 debut for biochip diagnostic
This article was originally published in Clinica
Executive Summary
Singapore firm Attogenix Biosystems is gearing up to take to market the first molecular test based on its rapid, sensitive and easy-to-use biochip technology: a diagnostic for Dengue fever.